Skip navigation

Strategies to Effectively Scale the Business and Best Practices for Accounting and Reporting

September 27-28, 2017
  • New Brunswick, NJ

CBI’s Finance & Accounting for Bioscience Companies convenes Finance and Accounting professionals from growing, innovative life sciences organizations to discuss best practices to implement scalable financial reporting processes, mitigate risk and develop lean and efficient finance teams. Birthed from the success of CBI’s Life Sciences Accounting and Reporting Congress, this meeting hones in on the unique challenges faced by small and mid-sized biotechs and pharmaceutical companies as they transition from private to public, enter into collaborations and recognize revenue. Gain strategies to ensure regulatory compliance, train new team members, manage contracts and effectively communicate financial performance.

Highlights for 2017 Include:

  • Implement new FASB Revenue Recognition standard
  • Optimize finance involvement in collaboration contract negotiations
  • Discuss IPO and accrual software to discover the best finance systems for your company
  • Navigate the evolution of financial processes as your company matures
  • Develop people and talent within your finance organization
  • Network with an elite speaking faculty and industry thought leaders

Download the Conference Preview

Previous Attendee Acclaim:

Great speakers with industry and function knowledge that spoke directly to issues I deal with.

Controller, Selecta Biosciences

CBI continues to deliver very insightful accounting practices specifically related to the life sciences industry.

Director, Technical Accounting and Controls, Amgen

I received real-time answers and tools for questions I was getting from my company’s leadership.

Senior Manager, Finance and Accounting, Endo Health Solutions

Very informative and helpful.

Senior Manager, Cubist Pharmaceuticals

September 27-28, 2017 | Hyatt Regency | New Brunswick, NJ

Finance & Accounting for Bioscience Companies

Strategies to Effectively Scale the Business and Best Practices for Accounting and Reporting

CBI’s Finance & Accounting for Bioscience Companies convenes Finance and Accounting professionals from growing, innovative life sciences organizations to discuss best practices to implement scalable financial reporting processes, mitigate risk and develop lean and efficient finance teams. Birthed from the success of CBI’s Life Sciences Accounting and Reporting Congress, this meeting hones in on the unique challenges faced by small and mid-sized biotechs and pharmaceutical companies as they transition from private to public, enter into collaborations and recognize revenue. Gain strategies to ensure regulatory compliance, train new team members, manage contracts and effectively communicate financial performance.

Highlights for 2017 Include:

  • Implement new FASB Revenue Recognition standard
  • Optimize finance involvement in collaboration contract negotiations
  • Discuss IPO and accrual software to discover the best finance systems for your company
  • Navigate the evolution of financial processes as your company matures
  • Develop people and talent within your finance organization
  • Network with an elite speaking faculty and industry thought leaders

Download the Conference Preview

Previous Attendee Acclaim:

Great speakers with industry and function knowledge that spoke directly to issues I deal with.

Controller, Selecta Biosciences

CBI continues to deliver very insightful accounting practices specifically related to the life sciences industry.

Director, Technical Accounting and Controls, Amgen

I received real-time answers and tools for questions I was getting from my company’s leadership.

Senior Manager, Finance and Accounting, Endo Health Solutions

Very informative and helpful.

Senior Manager, Cubist Pharmaceuticals

September 27-28, 2017 | Hyatt Regency | New Brunswick, NJ